Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1972 1
1974 1
1975 3
1976 4
1977 1
1978 6
1979 10
1980 8
1981 4
1982 8
1983 14
1984 13
1985 9
1986 20
1987 12
1988 10
1989 8
1990 6
1991 13
1992 14
1993 6
1994 6
1995 9
1996 6
1997 5
1998 6
1999 7
2000 9
2001 5
2002 6
2003 8
2004 6
2005 3
2006 4
2007 1
2008 1
2009 3
2010 1
2011 1
2012 1
2013 1
2014 2
2015 1
2017 1
2018 2
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

268 results
Results by year
Filters applied: . Clear all
Page 1
Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
Lähteenmäki R, Neuvonen PJ, Puustinen J, Vahlberg T, Partinen M, Räihä I, Kivelä SL. Lähteenmäki R, et al. Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):330-340. doi: 10.1111/bcpt.13144. Epub 2018 Dec 3. Basic Clin Pharmacol Toxicol. 2019. PMID: 30295409 Free article. Clinical Trial.
We studied perceived sleep and quality of life in 92 older (age 55-91 years) outpatients with primary insomnia before and after withdrawal from long-term use of zopiclone, zolpidem or temazepam (BZDA). BZDA was withdrawn during 1 month, during which the participants receiv …
We studied perceived sleep and quality of life in 92 older (age 55-91 years) outpatients with primary insomnia before and after withdrawal f …
Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
Arbon EL, Knurowska M, Dijk DJ. Arbon EL, et al. J Psychopharmacol. 2015 Jul;29(7):764-76. doi: 10.1177/0269881115581963. Epub 2015 Apr 28. J Psychopharmacol. 2015. PMID: 25922426 Clinical Trial.
In an entire night analysis prolonged-release melatonin did not affect SWA, whereas temazepam and zolpidem significantly reduced SWA compared with placebo. Temazepam significantly reduced SWA compared with prolonged-release melatonin. ...
In an entire night analysis prolonged-release melatonin did not affect SWA, whereas temazepam and zolpidem significantly reduced SWA …
Clinical trials of hypnotics.
Rickels K. Rickels K. J Clin Psychopharmacol. 1983 Apr;3(2):133-9. J Clin Psychopharmacol. 1983. PMID: 6132932 Review.
This article reviews the clinical literature of flurazepam, temazepam, and triazolam. The long half-life drug flurazepam and the short half-life drug triazolam produced similar results in terms of clinical improvement and adverse effects when equivalent dosages were admini …
This article reviews the clinical literature of flurazepam, temazepam, and triazolam. The long half-life drug flurazepam and the shor …
Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby JA, Kales JD. Kales A, et al. Clin Pharmacol Ther. 1986 Mar;39(3):345-52. doi: 10.1038/clpt.1986.51. Clin Pharmacol Ther. 1986. PMID: 2868823 Clinical Trial.
Quazepam, 15 mg, was significantly effective in improving sleep both with short- and intermediate-term use, but the effectiveness of temazepam was considerably less. Although temazepam was effective for maintaining sleep with short-term use, there was rapid developm …
Quazepam, 15 mg, was significantly effective in improving sleep both with short- and intermediate-term use, but the effectiveness of tema
Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam.
Okuma T, Matsuoka H, Matsue Y, Toyomura K. Okuma T, et al. Psychopharmacology (Berl). 1982;76(3):201-8. doi: 10.1007/BF00432545. Psychopharmacology (Berl). 1982. PMID: 6124991 Clinical Trial.
Experimental sleep disturbances (model insomnia) were produced by the administration of methylphenidate (MPD) 10 mg and caffeine (CAF) 150 mg. The effect of temazepam (TEM), 15 mg or 30 mg, on the model was investigated. All-night polysomnography was performed on 8 normal …
Experimental sleep disturbances (model insomnia) were produced by the administration of methylphenidate (MPD) 10 mg and caffeine (CAF) 150 m …
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Morgan K, et al. Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68. doi: 10.3310/hta8080. Health Technol Assess. 2004. PMID: 14960254 Free article. Review.
At the 3-month follow-up low-frequency drug use was reported by 22.9% (8/35) of temazepam users, 33.3% (5/15) of nitrazepam users and 38.9% (7/18) of zopiclone users. ...
At the 3-month follow-up low-frequency drug use was reported by 22.9% (8/35) of temazepam users, 33.3% (5/15) of nitrazepam users and …
Clinical pharmacology of ondansetron in postoperative nausea and vomiting.
Baber N, Palmer JL, Frazer NM, Pritchard JF. Baber N, et al. Eur J Anaesthesiol Suppl. 1992 Nov;6:11-8. Eur J Anaesthesiol Suppl. 1992. PMID: 1425620 Review.
Respiratory depression induced during general anaesthesia is not potentiated by ondansetron. No drug interactions have been noted with temazepam, atracurium, alfentanil and alcohol in man. There are also no interactions seen in animal studies using pentobarbitone, morphine …
Respiratory depression induced during general anaesthesia is not potentiated by ondansetron. No drug interactions have been noted with te
Hypnotic activity of melatonin.
Stone BM, Turner C, Mills SL, Nicholson AN. Stone BM, et al. Sleep. 2000 Aug 1;23(5):663-9. Sleep. 2000. PMID: 10947034 Clinical Trial.
Temazepam reduced body temperature 4.5 to 6.5 h post-ingestion. There were no changes in performance compared with placebo. ...Hypnotic activity of melatonin when given in the early evening (presumably in the absence of endogenous melatonin) is similar to 20 mg temazepa
Temazepam reduced body temperature 4.5 to 6.5 h post-ingestion. There were no changes in performance compared with placebo. ...Hypnot
Effects of temazepam, flurazepam and quinalbarbitone on sleep: psychomotor and cognitive function.
Roth T, Piccione P, Salis P, Kramer M, Kaffeman M. Roth T, et al. Br J Clin Pharmacol. 1979;8(1):47S-54S. doi: 10.1111/j.1365-2125.1979.tb00456.x. Br J Clin Pharmacol. 1979. PMID: 41542 Free PMC article. Clinical Trial.
1 The effect of temazepam 15 and 30 mg, flurazepam 15 and 30 mg, quinalbarbitone 100 and 200 mg and placebo were studied in 14 healthy male volunteers according to a Latin-square design. ...Subjective assessments of alertness were most affected by flurazepam, and by quinal …
1 The effect of temazepam 15 and 30 mg, flurazepam 15 and 30 mg, quinalbarbitone 100 and 200 mg and placebo were studied in 14 health …
Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem.
Carberry JC, Fisher LP, Grunstein RR, Gandevia SC, McKenzie DK, Butler JE, Eckert DJ. Carberry JC, et al. Eur Respir J. 2017 Dec 28;50(6):1701344. doi: 10.1183/13993003.01344-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29284686 Free article. Clinical Trial.
This study aimed to determine the effects of three common hypnotics on the respiratory arousal threshold, genioglossus muscle responsiveness and upper airway collapsibility during sleep.21 individuals with and without OSA (18-65 years) completed 84 detailed sleep studies after re …
This study aimed to determine the effects of three common hypnotics on the respiratory arousal threshold, genioglossus muscle responsiveness …
268 results